You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 157 No. 1, January 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Psychiatry
 •Adolescent Psychiatry
 •Attention Deficit Hyperactivity Disorder
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mirror, Mirror on the Wall

Are We Prescribing the Right Psychotropic Medications to the Right Children Using the Right Treatment Plan?

Arch Pediatr Adolesc Med. 2003;157:14-16.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

DURING THE period (1987-1996) reported by Zito et al,1 researchers from the field of child and adolescent psychiatry and pediatrics conducted studies to refine diagnostic criteria, applied these criteria to determine the prevalence of child psychiatric disorders, and provided the infrastructure for treatment studies. The research also led to greater standardization of an "evaluation" that facilitated an expectation that a formal diagnosis and treatment plan could be achieved in 1 or 2 hours. New medications emerged that were studied in adults but used widely for children as well. This clinical evolution was taking place in the context of dramatic changes in the health care delivery system secondary to managed care cost controls being applied for both general pediatric care and child mental health services.2 The data reported by Zito et al1 are a reflection, an imperfect mirror, of the scientific, clinical, financial, and systems changes that affected the care of . . . [Full Text of this Article]

CLINICAL PERSPECTIVE


FINANCIAL PERSPECTIVE

SYSTEMS PERSPECTIVES

NEXT STEPS


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Psychotropic Practice Patterns for Youth: A 10-Year Perspective
Julie Magno Zito, Daniel J. Safer, Susan dosReis, James F. Gardner, Laurence Magder, Karen Soeken, Myde Boles, Frances Lynch, and Mark A. Riddle
Arch Pediatr Adolesc Med. 2003;157(1):17-25.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psychotropic Medication Use in Pediatric Patients With Cancer
Pao et al.
Arch Pediatr Adolesc Med 2006;160:818-822.
ABSTRACT | FULL TEXT  

Are Too Many Children Taking Psychotropic Medicines?
JWatch Psychiatry 2003;2003:9-9.
FULL TEXT  

Are Too Many Children Taking Psychotropic Medicines?
Journal Watch Dermatology 2003;2003:8-8.
FULL TEXT  

Are Too Many Children Taking Psychotropic Medicines?
JWatch General 2003;2003:7-7.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.